Linna Peng
Impact in
-
- RNA modifications and cancer
- RNA Research and Splicing
- Genomics and Chromatin Dynamics
- RNA and protein synthesis mechanisms
- Epigenetics and DNA Methylation
- Single-cell and spatial transcriptomics
Papers in
-
- Genomics and Chromatin Dynamics 3
- Cancer-related gene regulation 3
- RNA Research and Splicing 3
- RNA modifications and cancer 2
- Epigenetics and DNA Methylation 2
- Surgery 3
- Esophageal Cancer Research and Treatment 3
- Co-authors
- Fei Chen (3 shared papers)Aixia Song (3 shared papers)Shibin Hu (3 shared papers)Zhenning Wang (1 shared paper)Congling Xu (1 shared paper)Dongxin Lin (7 shared papers)Wen Tan (7 shared papers)Chen Wu (7 shared papers)
- Journals
- Molecular Cell (2 papers)Cancer Communications (1 paper)Cancer Letters (1 paper)Nature Communications (1 paper)Science Advances (1 paper)
- Partner nations
- ChinaUnited StatesLaos
In The Last Decade
Linna Peng
12 papers receiving 331 citations
Peers
Comparison fields: 5 of 52
- Cancer Research 63
- Molecular Biology 243
- Oncology 74
- Immunology 51
- Biomaterials 19
Countries citing papers authored by Linna Peng
This map shows the geographic impact of Linna Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linna Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linna Peng more than expected).
Fields of papers citing papers by Linna Peng
This network shows the impact of papers produced by Linna Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linna Peng. The network helps show where Linna Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Linna Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 88 | |
| 2 | 2021 | 63 | |
| 3 | 2022 | 35 | |
| 4 | 2023 | 30 | |
| 5 | 2019 | 30 | |
| 6 | 2020 | 27 | |
| 7 | 2017 | 19 | |
| 8 | 2018 | 14 | |
| 9 | 2017 | 11 | |
| 10 | 2018 | 7 | |
| 11 | 2017 | 6 | |
| 12 | 2016 | 2 |
About Linna Peng
Linna Peng is a scholar working on Molecular Biology, Surgery, Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 12 papers that have together received 332 indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (3 papers), Cancer-related gene regulation (3 papers), RNA Research and Splicing (3 papers), Esophageal Cancer Research and Treatment (3 papers), Cancer Genomics and Diagnostics (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), RNA modifications and cancer (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (63 citations), Molecular Biology (243 citations), Oncology (74 citations), Immunology (51 citations) and Biomaterials (19 citations). Linna Peng has collaborated with scholars based in China, United States and Laos. Frequent co-authors include Fei Chen, Aixia Song, Shibin Hu, Zhenning Wang, Congling Xu, Dongxin Lin, Wen Tan, Chen Wu, Yingying Luo and Qionghua Cui. Their work appears in journals such as Molecular Cell, Cancer Communications, Cancer Letters, Nature Communications and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.